Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feng-Cai Zhu

Showing results (11-20 of 118) with videos related to

Pageof 12
Sort By:
Expert Review of Vaccines|July 28, 2023
A China-developed adenovirus vector-based COVID-19 vaccine: review of the development and application of Ad5-nCovShen-Yu Wang, Wen-Qing Liu, Yu-Qing Li, et al.
Human Vaccines & Immunotherapeutics|November 28, 2013
How to understand the efficacy measurements for enterovirus type 71 vaccine?Jing-Xin Li, Fan-Yue Meng, Zheng-Lun Liang, et al.
Chinese Medical Journal|August 3, 2021
Coronavirus disease 2019 vaccines: landscape of global studies and potential risksHu-Da-Chuan Jiang, Yan-Yang Tao, Si-Yue Jia, et al.
Archives of Virology|February 15, 2015
Echovirus 7 associated with hand, foot, and mouth disease in mainland China has undergone a recombination eventXin Yao, Lian-Lian Bian, Qun-Ying Mao, et al.
Human Vaccines & Immunotherapeutics|April 28, 2015
Comparing the immunogenicity and safety of 3 Japanese encephalitis vaccines in Asia-Pacific area: A systematic review and meta-analysisShi-Yuan Wang, Xiao-Hua Cheng, Jing-Xin Li, et al.
Expert Review of Vaccines|January 12, 2021
Quadrivalent influenza vaccine (Sinovac Biotech) for seasonal influenza prophylaxisYan-Yang Tao, Jing-Xin Li, Yue-Mei Hu, et al.
Vaccine|July 8, 2008
Safety and immunogenicity of two subunit influenza vaccines in healthy children, adults and the elderly: a randomized controlled trial in ChinaFeng Cai Zhu, Weizhong Zhou, Hongxing Pan, et al.
Human Vaccines & Immunotherapeutics|April 25, 2015
Evaluation of vaccine seroresponse rates and adverse event rates through Bayesian and frequentist methodsJin Liu, Feng Chen, Feng-Cai Zhu, et al.
Chinese Journal of Cancer|August 2, 2011
Safety and immunogenicity of human papillomavirus-16/18 AS04-adjuvanted vaccine in healthy Chinese females aged 15 to 45 years: a phase I trialFeng-Cai Zhu, Chang-Gui Li, Hong-Xing Pan, et al.
Human Vaccines & Immunotherapeutics|July 10, 2015
Disease burden of enterovirus 71 in rural central China: A community-based surveyZheng-kai Gan, Hui Jin, Jing-xin Li, et al.
Pageof 12

Showing results (11-20 of 118) with videos related to

Sort By:
Pageof 12
Expert Review of Vaccines|July 28, 2023
A China-developed adenovirus vector-based COVID-19 vaccine: review of the development and application of Ad5-nCovShen-Yu Wang, Wen-Qing Liu, Yu-Qing Li, et al.
Human Vaccines & Immunotherapeutics|November 28, 2013
How to understand the efficacy measurements for enterovirus type 71 vaccine?Jing-Xin Li, Fan-Yue Meng, Zheng-Lun Liang, et al.
Chinese Medical Journal|August 3, 2021
Coronavirus disease 2019 vaccines: landscape of global studies and potential risksHu-Da-Chuan Jiang, Yan-Yang Tao, Si-Yue Jia, et al.
Archives of Virology|February 15, 2015
Echovirus 7 associated with hand, foot, and mouth disease in mainland China has undergone a recombination eventXin Yao, Lian-Lian Bian, Qun-Ying Mao, et al.
Human Vaccines & Immunotherapeutics|April 28, 2015
Comparing the immunogenicity and safety of 3 Japanese encephalitis vaccines in Asia-Pacific area: A systematic review and meta-analysisShi-Yuan Wang, Xiao-Hua Cheng, Jing-Xin Li, et al.
Expert Review of Vaccines|January 12, 2021
Quadrivalent influenza vaccine (Sinovac Biotech) for seasonal influenza prophylaxisYan-Yang Tao, Jing-Xin Li, Yue-Mei Hu, et al.
Vaccine|July 8, 2008
Safety and immunogenicity of two subunit influenza vaccines in healthy children, adults and the elderly: a randomized controlled trial in ChinaFeng Cai Zhu, Weizhong Zhou, Hongxing Pan, et al.
Human Vaccines & Immunotherapeutics|April 25, 2015
Evaluation of vaccine seroresponse rates and adverse event rates through Bayesian and frequentist methodsJin Liu, Feng Chen, Feng-Cai Zhu, et al.
Chinese Journal of Cancer|August 2, 2011
Safety and immunogenicity of human papillomavirus-16/18 AS04-adjuvanted vaccine in healthy Chinese females aged 15 to 45 years: a phase I trialFeng-Cai Zhu, Chang-Gui Li, Hong-Xing Pan, et al.
Human Vaccines & Immunotherapeutics|July 10, 2015
Disease burden of enterovirus 71 in rural central China: A community-based surveyZheng-kai Gan, Hui Jin, Jing-xin Li, et al.
Pageof 12